Literature DB >> 2965554

Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

M Tishler1, D Caspi, E Gazit, M Yaron.   

Abstract

Seventy-four Israeli patients with rheumatoid arthritis (RA) were studied for possible association between HLA antigens and adverse reactions to gold treatment (aurothioglucose). HLA-B35 was significantly increased in patients who developed gold induced mucocutaneous lesions. These results are in accord with earlier reports, despite the different genetic background of the Israeli RA population and the different type of gold compound used.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2965554      PMCID： PMC1003486          DOI： 10.1136/ard.47.3.215

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  14 in total

1.  Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.

Authors:  G Ferraccioli; F Peri; A Nervetti; U Ambanelli; M Savi
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

2.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

3.  Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy.

Authors:  H G Nüsslein; H Jahn; G Lösch; I Guggenmoos-Holzmann; W Leibold; J R Kalden
Journal:  Arthritis Rheum       Date:  1984-07

Review 4.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

Authors:  P I Terasaki; D Bernoco; M S Park; G Ozturk; Y Iwaki
Journal:  Am J Clin Pathol       Date:  1978-02       Impact factor: 2.493

5.  A systematic survey of HLA-A,B,C and D antigens and drug toxicity in rheumatoid arthritis.

Authors:  J Dequeker; P Van Wanghe; W Verdickt
Journal:  J Rheumatol       Date:  1984-06       Impact factor: 4.666

6.  HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.

Authors:  O Scherak; J S Smolen; W R Mayr; F Mayrhofer; G Kolarz; N J Thumb
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

7.  HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.

Authors:  W G Bensen; N Moore; P Tugwell; M D'Souza; D P Singal
Journal:  J Rheumatol       Date:  1984-06       Impact factor: 4.666

8.  A study of HLA antigen association in localized and generalized granuloma annulare.

Authors:  R Friedman-Birnbaum; O Gideoni; R Bergman; S Pollack
Journal:  Br J Dermatol       Date:  1986-09       Impact factor: 9.302

9.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

10.  B lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis.

Authors:  G S Panayi; P H Wooley
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103
View more
  2 in total

1.  Similarity of the genetic background in rheumatic diseases between northern Italian and Israeli patients.

Authors:  G F Ferraccioli; G Bianchi; M Savi
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

2.  Association between gold induced skin rash and remission in patients with rheumatoid arthritis.

Authors:  D Caspi; M Tishler; M Yaron
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.